At the first stage of our research, we demonstrated that intranasally administered GRP78 penetrates the mammalian brain and is internalized by DA neurons in the SNpc and other brain regions that can be affected by PD in humans (Figure S2). Here, HSPA5 is linked to Parkinson disease.